Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

(in thousands)

Sale of critical reagents to Genezen

$

—

$

—

$

6,000

$

—

Research and development grants from Dutch authorities

1,013

1,071

4,124

3,957

Sublease income

488

333

1,747

658

Gain on sale of commercial manufacturing activities

—

1,171

—

1,171

Other

9

16

542

164

Total

$

1,510

$

2,591

$

12,413

$

5,950